Fosmanogepix tautomerism (APX001 tautomerism) is a broad-spectrum, orally effective compound for the treatment of invasive fungal infections. It targets the conserved fungal enzyme Gwt1, which is essential for the proper localization of glycosylphosphatidylinositol (GPI)-anchored mannoproteins. Inhibition of Gwt1 disrupts cell wall integrity, biofilm formation, germ tube formation, and fungal growth. Fosmanogepix tautomerism is used in the research and treatment of invasive fungal infection diseases.